Patients report experiencing reduced hunger, earlier feelings of fullness, fewer cravings for calorically dense foods, increased energy levels, and improvements in blood pressure, cholesterol, and blood sugar
At least I have the energy to keep on doing, keep on doing what my provider, what my doctor wants me to do
However, a recent consensus report addressed the growing interest in GLP-1 receptor agonists as an adjunctive therapy for T1D and their potential to improve glycemic and metabolic outcomes without increasing the risk of severe hypoglycemia or diabetic ketoacidosis. Lets examine GLP-1 therapies and SGLT inhibitors and consider how drugs like Ozempic may one day help people with type 1 diabetes
AOD-9604: A modified fragment of human growth hormone that stimulates lipolysis without affecting blood sugar or insulin levels
Your free consultation is the best place to get answers specific to your health and situation